Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 118 transactions totaling $1.1M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Jun 22, 2022 involved a transaction of 1,358,122 shares valued at $0.
MTNB Insider Activity Summary
Who Is Buying MTNB Stock?
No significant insider buying has been recorded for MTNB in the recent period.
Who Is Selling MTNB Stock?
No significant insider selling has been recorded for MTNB in the recent period.
Is Matinas BioPharma Holdings, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MTNB is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MTNB Frequently Asked Questions
Understanding MTNB Insider Activity
Insider trading at Matinas BioPharma Holdings, Inc. (MTNB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading MTNB stock, having executed 118 transactions in the past 90 days. The most active insider is Jennifer Lorenzo (Executive), who has made 1 transactions totaling $1.0M.
Related Tools
Track Matinas BioPharma Holdings, Inc. Insider Activity
Get notified when executives and directors at MTNB file new Form 4 transactions